Mitchell Schnall to continue as ECOG-ACRIN Cancer Research Group co-chair

MD Anderson, C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy

MD Anderson Cancer Center and C-Biomex Ltd. have formed a strategic research collaboration agreement to co-develop CBT-001, a radioligand targeting the CA9 cancer biomarker.

February 16, 2024

Vol.50 No.07

White House

As Biden invokes wartime powers to regulate AI, oncology braces for fundamental change

Invoking the Defense Production Act, President Joe Biden has ordered federal agencies and artificial intelligence companies to create safeguards and standards for the technology that has the capacity to uplift humankind as much as it can wreak unimaginable harm.

November 17, 2023

Vol.49 No.43

By Matthew Bin Han Ong

Conversation with The Cancer Letter

Paige’s Razik Yousfi: Biden has set expectations for AI, but details will come via federal guidelines

As a data scientist and software engineer, Razik Yousfi builds artificial intelligence models in health care. He started doing this 15 years ago, long before advanced chatbots catapulted AI into the layman’s consciousness.

November 17, 2023

Vol.49 No.43

By Matthew Bin Han Ong

Health Equity

ECOG-ACRIN renames health equity scholarships in honor of Edith Mitchell

The ECOG-ACRIN Cancer Research Group has renamed its Group Meeting Attendance Awards for Minority Trainees to the Edith Peterson Mitchell, MD Health Equity Travel Scholarships.

November 03, 2023

Vol.49 No.41

By Matthew Bin Han Ong

In Brief

Fatemeh Ardeshir, Andrew Srisuwananukorn receive ECOG-ACRIN Awards of Distinction

Fatemeh ArdeshirAndrew SrisuwananukornFatemeh Ardeshir and Andrew Srisuwananukorn, two presenters from the 23rd annual Young Investigator Symposium of the ECOG-ACRIN Cancer Research Group have received awards of distinction—a yearly tradition.

November 03, 2023

Vol.49 No.41

In Brief

Fox Chase invests in Nucleus RadioPharma

Fox Chase Cancer Center has invested in Nucleus RadioPharma, a company specializing in the development and distribution of radiopharmaceuticals, targeted therapies that deliver radiation directly to cancer cells.

October 27, 2023

Vol.49 No.40

Mitchell Schnall to continue as ECOG-ACRIN Cancer Research Group co-chair

YOU MAY BE INTERESTED IN

MD Anderson, C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy

As Biden invokes wartime powers to regulate AI, oncology braces for fundamental change

Paige’s Razik Yousfi: Biden has set expectations for AI, but details will come via federal guidelines

ECOG-ACRIN renames health equity scholarships in honor of Edith Mitchell

Fatemeh Ardeshir, Andrew Srisuwananukorn receive ECOG-ACRIN Awards of Distinction

Fox Chase invests in Nucleus RadioPharma

Renew today!

Subscriber content

Login